» Articles » PMID: 26688720

Efficacy of the Decolonization of Methicillin-resistant Staphylococcus Aureus Carriers in Clinical Practice

Overview
Publisher Biomed Central
Date 2015 Dec 22
PMID 26688720
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nasal and extra nasal carriage of methicillin-resistant S. aureus (MRSA) is a pre-existing condition that often leads to invasive MRSA infection, as MRSA colonization is associated with a high risk of acquiring MRSA infection during hospital stays. Decolonization may reduce the risk of meticillin-resistant Staphylococcus aureus (MRSA) infection in individual carriers and prevent transmission to other patients.

Methods: A retrospective cohort study was conducted to evaluate the effectiveness of two decolonization protocols for newly diagnosed MRSA carriage in hospitalized patients and to assess the impact of decolonization on the rate of MRSA infection. The study population consisted of all patients diagnosed as MRSA-positive between January 2006 and June 2010. Patients diagnosed as carriers were designated as requiring contact precautions by the hospital infection control team. The standing order protocol of the hospital pertaining to decolonization procedures was then applied, and all newly diagnosed patients were administered one of the two decolonization treatments outlined in the hospital protocol, with the exception of MRSA respiratory carriers (MRSA obtained from sputum or other lower respiratory tract samples). The two decolonization treatments consisted of the application of intranasal mupirocin 2 % and washing with chlorhexidine soap (40 mg/mL) (mupi/CHX) or application of intranasal povidone-iodine and washing with povidone-iodine soap (PVPI), with each treatment lasting for 5 days. Success was determined by at least three successive nose swabs and throat and other screened site swabs that tested negative for MRSA before patient discharge.

Results: A total of 1150 patients admitted to the hospital were found to be infected or colonized with MRSA. Of the 1150 patients, 268 were prescribed decolonization treatment. 104 out of 268 patients (39 %) were successfully decolonized. There was no significant success after two decolonization failures. MRSA infection rate among the successes and failures were 0.0 and 4.3 %, respectively [P = 0.04].

Conclusions: Our results fit well with the prescription of decolonization based on local strategy protocols but reflect a low rate of successful treatment. Although the success rate of decolonization was not high in our study, the effectiveness of decolonization on the infection rate, justifies the continuation of this strategy, even if a marginal cost is incurred.

Citing Articles

Preoperative MRSA screening using a simple questionnaire prior elective total joint replacement.

von Rehlingen-Prinz F, Rohrs M, Sandiford N, Garcia E, Schulmeyer J, Salber J Arch Orthop Trauma Surg. 2024; 144(12):5157-5164.

PMID: 38653834 DOI: 10.1007/s00402-024-05315-4.


Biofilm Producing Methicillin-Resistant (MRSA) Infections in Humans: Clinical Implications and Management.

Kaushik A, Kest H, Sood M, Steussy B, Thieman C, Gupta S Pathogens. 2024; 13(1).

PMID: 38251383 PMC: 10819455. DOI: 10.3390/pathogens13010076.


Nasal microbiota profiles in shelter dogs with dermatological conditions carrying methicillin-resistant and methicillin-sensitive Staphylococcus species.

Horsman S, Meler E, Mikkelsen D, Mallyon J, Yao H, Soares Magalhaes R Sci Rep. 2023; 13(1):4844.

PMID: 36964169 PMC: 10039040. DOI: 10.1038/s41598-023-31385-2.


Risk of methicillin-resistant prosthetic joint infection in elective total hip and knee arthroplasty following eradication therapy.

Jayaweera J World J Orthop. 2022; 13(7):676-678.

PMID: 36051372 PMC: 9302028. DOI: 10.5312/wjo.v13.i7.676.


Modeling Interventions to Reduce the Spread of Multidrug-Resistant Organisms Between Health Care Facilities in a Region.

Bartsch S, Wong K, Mueller L, Gussin G, McKinnell J, Tjoa T JAMA Netw Open. 2021; 4(8):e2119212.

PMID: 34347060 PMC: 8339938. DOI: 10.1001/jamanetworkopen.2021.19212.


References
1.
Harbarth S, Dharan S, Liassine N, Herrault P, Auckenthaler R, Pittet D . Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1999; 43(6):1412-6. PMC: 89288. DOI: 10.1128/AAC.43.6.1412. View

2.
Kampf G . The value of using chlorhexidine soap in a controlled trial to eradicate MRSA in colonized patients. J Hosp Infect. 2004; 58(1):86-7. DOI: 10.1016/j.jhin.2004.05.006. View

3.
Meyer V, Kerk N, Mellmann A, Friedrich A, Luger T, Goerge T . MRSA eradication in dermatologic outpatients - theory and practice. J Dtsch Dermatol Ges. 2012; 10(3):186-96. DOI: 10.1111/j.1610-0387.2011.07861.x. View

4.
Gemmell C, Edwards D, Fraise A, Gould F, Ridgway G, Warren R . Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemother. 2006; 57(4):589-608. DOI: 10.1093/jac/dkl017. View

5.
Ridenour G, Lampen R, Federspiel J, Kritchevsky S, Wong E, Climo M . Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients. Infect Control Hosp Epidemiol. 2007; 28(10):1155-61. DOI: 10.1086/520102. View